Feature ImpediMed sees revenue upswing from new SaaS business model ImpediMed’s (ASX:IPD) transition to a software-as-a-service (SaaS) subscription business model in 2018, in conjunction with the introduction of the SOZO Digital Health Platform, is already paying off on the top line. February 12, 2019